General medical information

Information on Hair-Loss Assessment

This page provides only a general scope and sources for Information on Hair-Loss Assessment. Personal suitability, the product or device used, potential benefit, risks, alternatives and the option of no procedure require a physician examination.

Direct answer

Hair loss can have different causes; the type of loss and possible underlying conditions should be assessed first.
A PRP or mesotherapy label alone does not establish suitability or outcome; content, protocol, evidence and alternatives require separate discussion.

Scope of this page

Online content is not diagnosis, prescribing, personal risk assessment or a treatment plan. A reference list is not a clinical sign-off; product and device information must also be checked against current Turkish registration and instructions for use.

Sources and evidence scope

These sources are editorial starting points. Each may be limited to a specific product, method, indication or study population.

Source titles remain in their publication language. Localized notes summarize the interpretation boundary and do not replace the full text. This translation has no recorded clinical or medical-language review.

Recommendations on the Clinical Management of Androgenetic Alopecia: A Consensus Statement From the Spanish Hair Disorders Group of the Spanish Academy of Dermatology and Venereology
S. Vañó-Galván et al.; Spanish Hair Disorders Research Group · 2024 · Clinical consensus
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local product or device information.
Editorial source — not a clinical sign-off record
Is autologous platelet-rich plasma capable of increasing hair density in patients with androgenic alopecia? A systematic review and meta-analysis of randomized clinical trials
L. Kieling, A. T. Konzen, R. K. Zanella and D. S. Valente · 2024 · Systematic review and meta-analysis
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local product or device information.
Editorial source — not a clinical sign-off record
Systematic review of mesotherapy: a novel avenue for the treatment of hair loss
A. K. Gupta, S. Polla Ravi, T. Wang, M. Talukder, M. Starace and B. M. Piraccini · 2023 · Systematic review
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local product or device information.
Editorial source — not a clinical sign-off record

Source-backed general information

PRP for hair loss: what does the evidence support—and not support?

PRP studies have focused particularly on androgenetic alopecia, but differing preparation methods, protocols and outcome measures do not support one universal schedule or a guaranteed result.

Mesotherapy for hair loss: why ask about the substance and limits of evidence?

Mesotherapy is not one medicine, substance or standard protocol. After diagnosis, ask which agent is being considered, for what purpose and on what evidence.

Why does hair loss require diagnosis first?

Androgenetic alopecia, telogen effluvium, alopecia areata, scarring alopecia and systemic causes do not share one appearance, course or treatment. Hair loss is not one diagnosis; no standard plan for PRP, mesotherapy or another procedure can be set before the cause is assessed.

Why do PRP preparation methods make outcomes hard to compare?

Blood volume, centrifugation, platelet and leukocyte content, activation, injection and reporting vary across studies. Hair loss is not one diagnosis; no standard plan for PRP, mesotherapy or another procedure can be set before the cause is assessed.

Why do standard photographs and measurements matter in hair follow-up?

Changes in hair length, parting, light, angle, wetness and camera can make density appear higher or lower. Hair loss is not one diagnosis; no standard plan for PRP, mesotherapy or another procedure can be set before the cause is assessed.

When does sudden hair loss need medical assessment?

Rapid onset, patches, scarring, pain or itch, redness, eyebrow or eyelash involvement or systemic symptoms should not be treated as only an aesthetic issue. Hair loss is not one diagnosis; no standard plan for PRP, mesotherapy or another procedure can be set before the cause is assessed.